{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:16:03Z","timestamp":1776672963709,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.pharep.2013.08.015","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T03:00:42Z","timestamp":1394161242000},"page":"471-479","source":"Crossref","is-referenced-by-count":25,"title":["A novel synthetic HTB derivative, BECT inhibits lipopolysaccharide-mediated inflammatory response by suppressing the p38 MAPK\/JNK and NF-\u03baB activation pathways"],"prefix":"10.1007","volume":"66","author":[{"given":"Seong-Mook","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep Vasant","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Park Jeong","family":"In","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hwa","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Kug","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"11 Suppl","key":"10.1016\/j.pharep.2013.08.015_bib0095","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.parkreldis.2004.10.013","article-title":"Neuroinflammatory processes in Parkinson's disease","volume":"1","author":"Hirsch","year":"2005","journal-title":"Parkinsonism Related Disorder"},{"key":"10.1016\/j.pharep.2013.08.015_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0969-9961(02)00017-7","article-title":"Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration","volume":"12","author":"Arimoto","year":"2003","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharep.2013.08.015_bib0130","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/mcne.2000.0914","article-title":"Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2","volume":"16","author":"Knott","year":"2000","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/j.pharep.2013.08.015_bib0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharep.2013.08.015_bib0045","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1523\/JNEUROSCI.18-05-01633.1998","article-title":"Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures","volume":"18","author":"Bhat","year":"1998","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharep.2013.08.015_bib0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1423-0127-18-28","article-title":"Aciculatin inhibits lipopolysaccharide-mediated inducible nitric oxide synthase and cyclooxygenase-2 expression via suppressing NF-kappaB and JNK\/p38 MAPK activation pathways","volume":"18","author":"Hsieh","year":"2011","journal-title":"Journal of Biomedical Science"},{"issue":"18 Suppl.","key":"10.1016\/j.pharep.2013.08.015_bib0100","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson's disease","volume":"1","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Related Disorder"},{"key":"10.1016\/j.pharep.2013.08.015_bib0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1749-6632.2008.03972.x","article-title":"The role of neuroimmunomodulation in Alzheimer's disease","volume":"1153","author":"Maccioni","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharep.2013.08.015_bib0005","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1161\/01.STR.0000028184.80776.58","article-title":"Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage","volume":"33","author":"Acarin","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.pharep.2013.08.015_bib0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(97)01518-5","article-title":"Comparison of in vitro effects of triflusal and acetysalicylic acid on nitric oxide synthesis by human neutrophils","volume":"343","author":"Sanchez de Miguel","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharep.2013.08.015_bib0065","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nbd.2010.01.019","article-title":"Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease","volume":"38","author":"Coma","year":"2010","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharep.2013.08.015_bib0200","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2010.10.008","article-title":"Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of Alzheimer's disease and stroke","volume":"1366","author":"Whitehead","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/j.pharep.2013.08.015_bib0035","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.bjp.0702441","article-title":"4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation","volume":"126","author":"Bayon","year":"1999","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharep.2013.08.015_bib0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0026-895X(24)23038-8","article-title":"Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid","volume":"55","author":"Fernandez de Arriba","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharep.2013.08.015_bib0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1254\/jphs.09239FP","article-title":"MMHD [(S,E)-2-methyl-1-(2-methylthiazol-4-yl) hexa-1 5-dien-ol], a novel synthetic compound derived from epothilone, suppresses nuclear factor-kappaB-mediated cytokine expression in lipopolysaccharide-stimulated BV-2 microglia","volume":"112","author":"Jeon","year":"2010","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.pharep.2013.08.015_bib0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1254\/jphs.10324FP","article-title":"Anti-neuroinflammatory activity of Kamebakaurin from Isodon japonicus via inhibition of c-Jun NH(2)-terminal kinase and p38 mitogen-activated protein kinase pathway in activated microglial cells","volume":"116","author":"Kim","year":"2011","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.pharep.2013.08.015_bib0055","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jnr.490310405","article-title":"An immortalized cell line expresses properties of activated microglial cells","volume":"31","author":"Bocchini","year":"1992","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharep.2013.08.015_bib0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.pharep.2013.08.015_bib0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jep.2010.05.006","article-title":"Protective effects of Gastrodia elata Blume on MPP+-induced cytotoxicity in human dopaminergic SH-SY5Y cells","volume":"130","author":"An","year":"2010","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.pharep.2013.08.015_bib0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2010.02.011","article-title":"Inflexin attenuates proinflammatory responses and nuclear factor-kappaB activation in LPS-treated microglia","volume":"633","author":"Ko","year":"2010","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharep.2013.08.015_bib0060","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2741\/1268","article-title":"Nitric oxide neurotoxicity in neurodegenerative diseases","volume":"9","author":"Boje KM:","year":"2004","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.pharep.2013.08.015_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(02)02480-0","article-title":"Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2","volume":"941","author":"Kim","year":"2002","journal-title":"Brain Research"},{"key":"10.1016\/j.pharep.2013.08.015_bib0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2000.tb05373.x","article-title":"The role of pro- and antiinflammatory cytokines in neurodegeneration","volume":"917","author":"Allan SM:","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharep.2013.08.015_bib0195","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1073\/pnas.96.17.9879","article-title":"A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide","volume":"96","author":"Venters","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharep.2013.08.015_bib0070","doi-asserted-by":"crossref","first-page":"28373","DOI":"10.1074\/jbc.272.45.28373","article-title":"Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes","volume":"272","author":"Da Silva","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharep.2013.08.015_bib0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0074-7742(07)82015-0","article-title":"Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches","volume":"82","author":"Van Eldik","year":"2007","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/j.pharep.2013.08.015_bib0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharep.2013.08.015_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/327089","article-title":"The endotoxin-induced neuroinflammation model of Parkinson's disease","volume":"2011","author":"Tufekci","year":"2011","journal-title":"Parkinson's Disease"},{"key":"10.1016\/j.pharep.2013.08.015_bib0155","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.bcp.2009.09.026","article-title":"A novel anti-neuroinflammatory pyridylimidazole compound KR-31360","volume":"79","author":"Ock","year":"2010","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharep.2013.08.015_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biochi.2010.09.009","article-title":"Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications","volume":"93","author":"Aid","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.pharep.2013.08.015_bib0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1242\/jeb.202.6.645","article-title":"Inducible NO synthase: role in cellular signalling","volume":"202","author":"Beck","year":"1999","journal-title":"Journal of Experimental Biology"},{"key":"10.1016\/j.pharep.2013.08.015_bib0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bjp.0703820","article-title":"Effect of 4-trifluoromethyl derivatives of salicylate on nuclear factor kappaB-dependent transcription in human astrocytoma cells","volume":"132","author":"Hernandez","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharep.2013.08.015_bib0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-4-47","article-title":"Does neuroinflammation fan the flame in neurodegenerative diseases?","volume":"4","author":"Frank-Cannon","year":"2009","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.pharep.2013.08.015_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1165\/ajrcmb.17.1.f132","article-title":"The role of nuclear factor-kappa B in cytokine gene regulation","volume":"17","author":"Blackwell","year":"1997","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharep.2013.08.015_bib0165","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/np200756f","article-title":"Inhibition of NF-kappaB-dependent cytokine and inducible nitric oxide synthesis by the macrocyclic ellagitannin oenothein B in TLR-stimulated RAW 264.7 macrophages","volume":"75","author":"Schmid","year":"2012","journal-title":"Journal of Natural Products"},{"key":"10.1016\/j.pharep.2013.08.015_bib0180","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/jcb.21717","article-title":"p38\/NF-kB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes","volume":"104","author":"Ulivi","year":"2008","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.pharep.2013.08.015_bib0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1248\/bpb.33.461","article-title":"Identification of KT-15073 as an inhibitor of lipopolysaccharide-induced microglial activation","volume":"33","author":"Ock","year":"2010","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharep.2013.08.015_bib0110","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","article-title":"JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease","volume":"101","author":"Hunot","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharep.2013.08.015_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1742-2094-8-79","article-title":"Microglial p38\u03b1 MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (A\u03b2)","volume":"8","author":"Bachstetter","year":"2011","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharep.2013.08.015_bib0185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00228-004-0887-0","article-title":"Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers","volume":"61","author":"Valle","year":"2005","journal-title":"European Journal of Clinical Pharmacology"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:15Z","timestamp":1752611715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2013.08.015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1734114014000474"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2013.08.015","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}